<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0010">
 <label>Table 2</label>
 <caption>
  <p>Immune mechanisms involved in CoV infection, cancer, chemotherapy and immunotherapy (responsive and resistant immune system).</p>
 </caption>
 <alt-text id="at0010">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Host condition</th>
    <th align="left">Neutrophils,
     <break/>monocytes
    </th>
    <th align="left">T cells</th>
    <th align="left">B cells</th>
    <th align="left">Dendritic cells</th>
    <th align="left">Other cell populations, soluble mediators</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="middle" rowspan="9">
     <bold>CoV infection</bold>
    </td>
    <td align="left" valign="middle" rowspan="9">↑ cytokine production</td>
    <td align="left">↑ activation</td>
    <td align="left" valign="middle" rowspan="9">↑ complement protein production (C3a, C5a)</td>
    <td align="left" valign="middle" rowspan="4"/>
    <td align="left" valign="middle" rowspan="4">↑ IL-1, IL-6, IL-8, IL-10, IL-21</td>
   </tr>
   <tr>
    <td align="left">↑ Th17 polarization</td>
   </tr>
   <tr>
    <td align="left">↑ CD4+ apoptosis</td>
   </tr>
   <tr>
    <td align="left">↓ CD4+ recruitment in lung tissue</td>
   </tr>
   <tr>
    <td align="left">↑ CD8+ infiltration in lung tissue</td>
    <td align="left">↓ maturation process</td>
    <td align="left">↑ MIF, MCP-1</td>
   </tr>
   <tr>
    <td align="left">↑ viral clearance and immune injury</td>
    <td align="left">↓ MHC class I expression</td>
    <td align="left">↑ TNF α/β</td>
   </tr>
   <tr>
    <td align="left">↓ T reg</td>
    <td align="left" valign="middle" rowspan="3">↓ viral Ag presentation</td>
    <td align="left">↑ type I IFN</td>
   </tr>
   <tr>
    <td align="left">↑ cytokine production</td>
    <td align="left">↑ VEGF</td>
   </tr>
   <tr>
    <td align="left">↑ neutrophils and monocytes recruitment</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="5">
     <bold>Cancer</bold>
    </td>
    <td align="left" valign="middle" rowspan="2">↑ polarization of N2 immunosuppressive neutrophils</td>
    <td align="left">↑ T reg</td>
    <td align="left" valign="middle" rowspan="5">↑ B reg</td>
    <td align="left" valign="middle" rowspan="2">↓ tumor Ag expression</td>
    <td align="left" valign="middle" rowspan="2">↑ TNF α</td>
   </tr>
   <tr>
    <td align="left">↑ Th 17</td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="2">↑ anti-inflammatory M2 macrophages</td>
    <td align="left">↑ expression of immune checkpoint ligands</td>
    <td align="left" valign="middle" rowspan="3">↓ MHC class I and II expression</td>
    <td align="left">↑ TGF β</td>
   </tr>
   <tr>
    <td align="left">↑ exhaustion</td>
    <td align="left">↑ IL-10</td>
   </tr>
   <tr>
    <td align="left">↑ MDSC</td>
    <td align="left">↓ proliferation and activation</td>
    <td align="left">↑ IFN-γ  production</td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="4">
     <bold>Cytotoxic chemotherapy</bold>
    </td>
    <td align="left" valign="middle" rowspan="4">↓ MDSC activity (gemcitabine, 5FU, CDDP, doxorubicin)</td>
    <td align="left" valign="middle" rowspan="2">↑ CD8+ cross priming (gemcitabine, anthracyclines)</td>
    <td align="left" valign="middle" rowspan="3"/>
    <td align="left" valign="middle" rowspan="2">↑ activation (anthracyclines, taxanes,</td>
    <td align="left">↑ IFN-γ production</td>
   </tr>
   <tr>
    <td align="left">↑ CXCL10</td>
   </tr>
   <tr>
    <td align="left">↑ CD4+ phenotype expression (cyclophosphamide, paclitaxel)</td>
    <td align="left">cyclophosphamide, vinca alkaloids, methotrexate)</td>
    <td align="left">↑ IL-1 β</td>
   </tr>
   <tr>
    <td align="left">↓ T reg activity (cyclophosphamide, 5FU, paclitaxel, CDDP)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left">↑ tumor cell recognition and lysis (cyclophosphamide, 5FU, paclitaxel, CDDP, doxorubicin)</td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="3">
     <bold>Immunotherapy</bold> (responsive immune system)
    </td>
    <td align="left" valign="middle" rowspan="3"/>
    <td align="left">↑ tumor Ag-specific T cell response</td>
    <td align="left" valign="middle" rowspan="3"/>
    <td align="left" valign="middle" rowspan="3"/>
    <td align="left">↑ IFN-γ production</td>
   </tr>
   <tr>
    <td align="left">↑ T cell migration and activation</td>
    <td align="left" valign="middle" rowspan="2">↑ co-stimulatory molecules expression (CD80, CD86, OX40, GITR, CD40)</td>
   </tr>
   <tr>
    <td align="left">↑ CD8+ tumor infiltrating lymphocytes</td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="8">
     <bold>Immunotherapy</bold> (resistant immune system)
    </td>
    <td align="left" valign="middle" rowspan="8">↑ MDSC</td>
    <td align="left">↑ T reg</td>
    <td align="left" valign="middle" rowspan="8"/>
    <td align="left" valign="middle" rowspan="4">↓ migration and maturation</td>
    <td align="left" valign="middle" rowspan="2">↓ chemokines expression (epigenetic silencing)</td>
   </tr>
   <tr>
    <td align="left">↑ Th 2</td>
   </tr>
   <tr>
    <td align="left">↓ priming</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">↓ T cell function</td>
    <td align="left">↑ PD-L1, endothelin B receptor</td>
   </tr>
   <tr>
    <td align="left">↓ T CD8+ tumor cell recognition</td>
    <td align="left">↓ tumor Ag expression</td>
    <td align="left">↑ CD73-adenosine</td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="2">↑ expression of immune checkpoint molecules (TIM-3, LAG-3, VISTA, BTLA)</td>
    <td align="left" valign="middle" rowspan="2">↓ MHC class I and II expression</td>
    <td align="left">↑ IFN-γ pathway</td>
   </tr>
   <tr>
    <td align="left">↑ VEGF</td>
   </tr>
   <tr>
    <td align="left">↑ exhaustion</td>
    <td align="left"/>
    <td align="left">↑ IL-8</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Abbreviations: Ag, antigen; BTLA, B- and T-lymphocyte attenuator; CD, cluster of differentiation; CDDP, cisplatin; CXCL10, C-X-C motif chemokine 10; GITR, glucocorticoid-induced TNFR-related protein; IFN, interferon; IL, interleukin; LAG-3, lymphocyte activation gene 3; MCP-1, monocyte chemoattractant protein 1; MDSC, myeloid-derived suppressor cell; MHC, major histocompatibility complex; MIF, macrophage migration inhibitory factor; PD-L1, programmed-death ligand 1; TGF, transforming growth factor; Th, T helper cell; TIM-3, T-cell immunoglobulin and mucin-domain containing-3; TNF, tumor necrosis factor; T reg, T regulatory cell; VEGF, vascular endothelial growth factor; VISTA, V-domain Ig suppressor of T cell activation; 5FU, 5-fluorouracil.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
